Identifying Sensitive Measures of Cognitive Decline at Different Clinical Stages of Alzheimer’s Disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identifying Sensitive Measures of Cognitive Decline at Different Clinical Stages of Alzheimer’s Disease
Authors
Keywords
-
Journal
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
Volume -, Issue -, Pages 1-13
Publisher
Cambridge University Press (CUP)
Online
2020-10-13
DOI
10.1017/s1355617720000934
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging–Alzheimer’s Association Research Framework
- (2019) Clifford R. Jack et al. JAMA Neurology
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- The importance of endpoint selection: How effective does a drug need to be for success in a clinical trial of a possible Alzheimer’s disease treatment?
- (2018) Stephanie Evans et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Amsterdam Dementia Cohort: Performing Research to Optimize Care
- (2018) Wiesje M. van der Flier et al. JOURNAL OF ALZHEIMERS DISEASE
- Harvard Aging Brain Study: Dataset and accessibility
- (2017) Alexander Dagley et al. NEUROIMAGE
- Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
- (2016) Bruno Dubois et al. Alzheimers & Dementia
- ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials
- (2016) Jinping Wang et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Mini Mental State Examination and Logical Memory scores for entry into Alzheimer’s disease trials
- (2016) Kimberly R. Chapman et al. Alzheimers Research & Therapy
- Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults
- (2015) Paula T. Trzepacz et al. BMC Geriatrics
- An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease
- (2014) Jessica B. Langbaum et al. Alzheimers & Dementia
- Amyloid and APOE 4 interact to influence short-term decline in preclinical Alzheimer disease
- (2014) E. C. Mormino et al. NEUROLOGY
- The Preclinical Alzheimer Cognitive Composite
- (2014) Michael C. Donohue et al. JAMA Neurology
- Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer’s disease: a selective review
- (2013) Dorene M Rentz et al. Alzheimers Research & Therapy
- Progression of Alzheimer’s disease as measured by Clinical Dementia Rating Sum of Boxes scores
- (2012) Monique M. Williams et al. Alzheimers & Dementia
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Use of Florbetapir-PET for Imaging β-Amyloid Pathology
- (2011) Christopher M. Clark JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical core of the Alzheimer's disease neuroimaging initiative: Progress and plans
- (2010) Paul S. Aisen et al. Alzheimers & Dementia
- The measurement of everyday cognition (ECog): Scale development and psychometric properties.
- (2008) Sarah Tomaszewski Farias et al. NEUROPSYCHOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started